Actinium Pharmaceuticals, Inc Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Actinium Pharmaceuticals, Inc stock downgraded from Buy Candidate to Hold/Accumulate after Friday trading session.
(Updated on May 03, 2024)
The Actinium Pharmaceuticals, Inc stock price gained 2.40% on the last trading day (Friday, 3rd May 2024), rising from $8.75 to $8.96. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 7.73% from a day low at $8.54 to a day high of $9.20. The price has risen in 8 of the last 10 days and is up by 30.8% over the past 2 weeks. Volume fell on the last day by -161 thousand shares and in total, 519 thousand shares were bought and sold for approximately $4.65 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 27.09% during the next 3 months and, with a 90% probability hold a price between $8.61 and $13.02 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ATNM Signals & Forecast
The Actinium Pharmaceuticals, Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $7.71 and $8.08. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, April 05, 2024, and so far it has fallen -6.08%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for Actinium Pharmaceuticals, Inc stock
Actinium Pharmaceuticals, Inc finds support from accumulated volume at $8.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.660 between high and low, or 7.73%. For the last week, the stock has had daily average volatility of 8.26%.
Since the Actinium Pharmaceuticals, Inc has been rising for 6 days in a row, the risk over the next couple of days has increased. As we cannot be certain with regards to the size of the reaction, we urge caution.
Our recommended stop-loss: $8.66 (-3.40%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from a pivot top found 20 days ago.)
Trading Expectations (ATNM) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect Actinium Pharmaceuticals, Inc to open at $8.90, and during the day (based on 14 day Average True Range), to move between $8.34 and $9.58, which gives a possible trading interval of +/-$0.619 (+/-6.91%) up or down from last closing price. If Actinium Pharmaceuticals, Inc takes out the full calculated possible swing range there will be an estimated 13.81% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $9.11 (1.67%) than the support at $8.60 (4.02%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Actinium Pharmaceuticals, Inc stock A Buy?
Actinium Pharmaceuticals, Inc holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
Current score: 0.940 Hold/Accumulate Downgraded
Predicted Opening Price for Actinium Pharmaceuticals, Inc of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $8.90 ( 0.670%) | $8.96 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ATNM
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 9.56 | 6.70 % | |
| R2 | 9.31 | 3.88 % | ||
| R1 | 9.15 | 2.14 % | ||
| Current price: | 8.96 | |||
| Support | S1 | 8.65 | -3.48 % | |
| S2 | 8.49 | -5.22 % | ||
| S3 | 8.24 | -8.04 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 9.20 | 2.68 % | |
| R2 | 9.13 | 1.90 % | ||
| R1 | 9.11 | 1.67 % | ||
| Current price | 8.96 | |||
| Support | S1 | 8.60 | -4.02% | |
| S2 | 8.31 | -7.25% | ||
| S3 | 8.21 | -8.37% |
FAQ
Click here for our free guide on how to buy Actinium Pharmaceuticals, Inc Stock.
